UPDATE 1-Biotech firm Ginkgo in talks with Harry Sloan-led SPAC for over $20 bln deal

Reuters2021-04-10

(Adds confirmation from source)

By Krystal Hu

April 9 (Reuters) - Biotech startup Ginkgo Bioworks is in talks to go public through a merger with a blank-check firm backed by former Hollywood executives Harry Sloan and Jeff Sagansky, in a deal valued at about $20 billion, a person familiar with the matter said.

The company is in exclusive talks with Soaring Eagle Acquisition Corp for a potential business combination and a deal could be announced as soon as this month, the source said on Friday.

Soaring Eagle declined to comment on the matter.

Boston-based Ginkgo is backed by Bill Gates' private investment firm, Cascade Investment, and hedge fund Viking Global. It received a $1.1 billion loan from the U.S. government in November for COVID-19 testing and production of raw materials for therapies that may help address future pandemics.

Soaring Eagle, a special purpose acquisition company (SPAC), raised $1.7 billion through an initial public offering in February.

Sloan, a former chief executive officer of Metro Goldwyn Mayer, and Sagansky's former SPACs took gaming firms DraftKings Inc and Skillz Inc public.

SPACs are shell companies that raise funds through an initial public offering to take a private company public through a merger at a later date.

(Reporting by Sohini Podder in Bengaluru; Editing by Shinjini Ganguli)

((sohini.podder@thomsonreuters.com;))

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

CHENRAN
2021-04-10
CHENRAN
利好吗？
Tayhs
2021-04-10
Tayhs
[开心]
Yeong
2021-04-10
Yeong
It going to be hot

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2126330720?lang=zh_CN&edition=full","thumbnail":"","is_english":true,"pubTime":"2021-04-10 00:18","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2126330720","market":"us","top_or_hot":-1,"title":"UPDATE 1-Biotech firm Ginkgo in talks with Harry Sloan-led SPAC for over $20 bln deal","media":"Reuters","content":"<html><body><p>(Adds confirmation from source)</p><p>   By Krystal Hu</p><p>   April 9 (Reuters) - Biotech startup Ginkgo Bioworks is in talks to go public through a merger with a blank-check firm backed by former Hollywood executives Harry Sloan and Jeff Sagansky, in a deal valued at about $20 billion, a person familiar with the matter said.</p><p>   The company is in exclusive talks with Soaring Eagle Acquisition Corp    for a potential business combination and a deal could be announced as soon as this month, the source said on Friday. </p><p>   Soaring Eagle declined to comment on the matter. </p><p>   Boston-based Ginkgo is backed by Bill Gates' private investment firm, Cascade Investment, and hedge fund Viking Global. It received a $1.1 billion loan from the U.S. government in November for COVID-19 testing and production of raw materials for therapies that may help address future pandemics.</p><p>   Soaring Eagle, a special purpose acquisition company (SPAC), raised $1.7 billion through an initial public offering in February. </p><p>   Sloan, a former chief executive officer of Metro Goldwyn Mayer, and Sagansky's former SPACs took gaming firms DraftKings Inc    and <a href=\"https://laohu8.com/S/SKLZ\">Skillz Inc</a>    public. </p><p>   SPACs are shell companies that raise funds through an initial public offering to take a private company public through a merger at a later date.</p><p> (Reporting by Sohini Podder in Bengaluru; Editing by Shinjini Ganguli)</p><p>((sohini.podder@thomsonreuters.com;))</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>UPDATE 1-Biotech firm Ginkgo in talks with Harry Sloan-led SPAC for over $20 bln deal</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nUPDATE 1-Biotech firm Ginkgo in talks with Harry Sloan-led SPAC for over $20 bln deal\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-04-10 00:18</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p>(Adds confirmation from source)</p><p>   By Krystal Hu</p><p>   April 9 (Reuters) - Biotech startup Ginkgo Bioworks is in talks to go public through a merger with a blank-check firm backed by former Hollywood executives Harry Sloan and Jeff Sagansky, in a deal valued at about $20 billion, a person familiar with the matter said.</p><p>   The company is in exclusive talks with Soaring Eagle Acquisition Corp    for a potential business combination and a deal could be announced as soon as this month, the source said on Friday. </p><p>   Soaring Eagle declined to comment on the matter. </p><p>   Boston-based Ginkgo is backed by Bill Gates' private investment firm, Cascade Investment, and hedge fund Viking Global. It received a $1.1 billion loan from the U.S. government in November for COVID-19 testing and production of raw materials for therapies that may help address future pandemics.</p><p>   Soaring Eagle, a special purpose acquisition company (SPAC), raised $1.7 billion through an initial public offering in February. </p><p>   Sloan, a former chief executive officer of Metro Goldwyn Mayer, and Sagansky's former SPACs took gaming firms DraftKings Inc    and <a href=\"https://laohu8.com/S/SKLZ\">Skillz Inc</a>    public. </p><p>   SPACs are shell companies that raise funds through an initial public offering to take a private company public through a merger at a later date.</p><p> (Reporting by Sohini Podder in Bengaluru; Editing by Shinjini Ganguli)</p><p>((sohini.podder@thomsonreuters.com;))</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"DKNG","symbol_name":"DraftKings Inc.","start_time":0,"source_url":"http://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","article_id":"2126330720","we_media_id":"1036604489","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2126330720","pubTimestamp":1617985100,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"summary":"(Adds confirmation from source)   By Krystal Hu   April 9 (Reuters) - Biotech startup Ginkgo Biowork","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"DKNG":"DraftKings Inc.","SRNGU":"Soaring Eagle Acquisition Corp.","SKLZ":"Skillz Inc"},"translate_title":"最新消息1-生物技术公司Ginkgo正在与Harry Sloan领导的SPAC公司商谈超过2000万美元的交易","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"DKNG":0.9,"SKLZ":0.9,"SRNGU":0.9},"content_text":"(Adds confirmation from source)   By Krystal Hu   April 9 (Reuters) - Biotech startup Ginkgo Bioworks is in talks to go public through a merger with a blank-check firm backed by former Hollywood executives Harry Sloan and Jeff Sagansky, in a deal valued at about $20 billion, a person familiar with the matter said.   The company is in exclusive talks with Soaring Eagle Acquisition Corp    for a potential business combination and a deal could be announced as soon as this month, the source said on Friday.    Soaring Eagle declined to comment on the matter.    Boston-based Ginkgo is backed by Bill Gates' private investment firm, Cascade Investment, and hedge fund Viking Global. It received a $1.1 billion loan from the U.S. government in November for COVID-19 testing and production of raw materials for therapies that may help address future pandemics.   Soaring Eagle, a special purpose acquisition company (SPAC), raised $1.7 billion through an initial public offering in February.    Sloan, a former chief executive officer of Metro Goldwyn Mayer, and Sagansky's former SPACs took gaming firms DraftKings Inc    and Skillz Inc    public.    SPACs are shell companies that raise funds through an initial public offering to take a private company public through a merger at a later date. (Reporting by Sohini Podder in Bengaluru; Editing by Shinjini Ganguli)((sohini.podder@thomsonreuters.com;))","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"code":"91000000","status":"200"},"commentList":[{"id":346320090,"gmtCreate":1618002619010,"gmtModify":1618002619010,"author":{"id":"3573448899686470","authorId":"3573448899686470","name":"CHENRAN","avatar":"https://static.tigerbbs.com/7c923fec79f1c24db830176d855dded3","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3573448899686470","authorIdStr":"3573448899686470"},"htmlText":"利好吗？","listText":"利好吗？","text":"利好吗？","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/346320090","repostId":2126330720,"repostType":2,"repost":{"id":"2126330720","kind":"highlight","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1617985100,"share":"https://ttm.financial/m/news/2126330720?lang=&edition=full","pubTime":"2021-04-10 00:18","market":"us","language":"en","title":"UPDATE 1-Biotech firm Ginkgo in talks with Harry Sloan-led SPAC for over $20 bln deal","url":"https://stock-news.laohu8.com/highlight/detail?id=2126330720","media":"Reuters","summary":"(Adds confirmation from source)   By Krystal Hu   April 9 (Reuters) - Biotech startup Ginkgo Biowork","content":"<html><body><p>(Adds confirmation from source)</p><p>   By Krystal Hu</p><p>   April 9 (Reuters) - Biotech startup Ginkgo Bioworks is in talks to go public through a merger with a blank-check firm backed by former Hollywood executives Harry Sloan and Jeff Sagansky, in a deal valued at about $20 billion, a person familiar with the matter said.</p><p>   The company is in exclusive talks with Soaring Eagle Acquisition Corp    for a potential business combination and a deal could be announced as soon as this month, the source said on Friday. </p><p>   Soaring Eagle declined to comment on the matter. </p><p>   Boston-based Ginkgo is backed by Bill Gates' private investment firm, Cascade Investment, and hedge fund Viking Global. It received a $1.1 billion loan from the U.S. government in November for COVID-19 testing and production of raw materials for therapies that may help address future pandemics.</p><p>   Soaring Eagle, a special purpose acquisition company (SPAC), raised $1.7 billion through an initial public offering in February. </p><p>   Sloan, a former chief executive officer of Metro Goldwyn Mayer, and Sagansky's former SPACs took gaming firms DraftKings Inc    and <a href=\"https://laohu8.com/S/SKLZ\">Skillz Inc</a>    public. </p><p>   SPACs are shell companies that raise funds through an initial public offering to take a private company public through a merger at a later date.</p><p> (Reporting by Sohini Podder in Bengaluru; Editing by Shinjini Ganguli)</p><p>((sohini.podder@thomsonreuters.com;))</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>UPDATE 1-Biotech firm Ginkgo in talks with Harry Sloan-led SPAC for over $20 bln deal</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nUPDATE 1-Biotech firm Ginkgo in talks with Harry Sloan-led SPAC for over $20 bln deal\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-04-10 00:18</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p>(Adds confirmation from source)</p><p>   By Krystal Hu</p><p>   April 9 (Reuters) - Biotech startup Ginkgo Bioworks is in talks to go public through a merger with a blank-check firm backed by former Hollywood executives Harry Sloan and Jeff Sagansky, in a deal valued at about $20 billion, a person familiar with the matter said.</p><p>   The company is in exclusive talks with Soaring Eagle Acquisition Corp    for a potential business combination and a deal could be announced as soon as this month, the source said on Friday. </p><p>   Soaring Eagle declined to comment on the matter. </p><p>   Boston-based Ginkgo is backed by Bill Gates' private investment firm, Cascade Investment, and hedge fund Viking Global. It received a $1.1 billion loan from the U.S. government in November for COVID-19 testing and production of raw materials for therapies that may help address future pandemics.</p><p>   Soaring Eagle, a special purpose acquisition company (SPAC), raised $1.7 billion through an initial public offering in February. </p><p>   Sloan, a former chief executive officer of Metro Goldwyn Mayer, and Sagansky's former SPACs took gaming firms DraftKings Inc    and <a href=\"https://laohu8.com/S/SKLZ\">Skillz Inc</a>    public. </p><p>   SPACs are shell companies that raise funds through an initial public offering to take a private company public through a merger at a later date.</p><p> (Reporting by Sohini Podder in Bengaluru; Editing by Shinjini Ganguli)</p><p>((sohini.podder@thomsonreuters.com;))</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"DKNG":"DraftKings Inc.","SRNGU":"Soaring Eagle Acquisition Corp.","SKLZ":"Skillz Inc"},"source_url":"http://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2126330720","content_text":"(Adds confirmation from source)   By Krystal Hu   April 9 (Reuters) - Biotech startup Ginkgo Bioworks is in talks to go public through a merger with a blank-check firm backed by former Hollywood executives Harry Sloan and Jeff Sagansky, in a deal valued at about $20 billion, a person familiar with the matter said.   The company is in exclusive talks with Soaring Eagle Acquisition Corp    for a potential business combination and a deal could be announced as soon as this month, the source said on Friday.    Soaring Eagle declined to comment on the matter.    Boston-based Ginkgo is backed by Bill Gates' private investment firm, Cascade Investment, and hedge fund Viking Global. It received a $1.1 billion loan from the U.S. government in November for COVID-19 testing and production of raw materials for therapies that may help address future pandemics.   Soaring Eagle, a special purpose acquisition company (SPAC), raised $1.7 billion through an initial public offering in February.    Sloan, a former chief executive officer of Metro Goldwyn Mayer, and Sagansky's former SPACs took gaming firms DraftKings Inc    and Skillz Inc    public.    SPACs are shell companies that raise funds through an initial public offering to take a private company public through a merger at a later date. (Reporting by Sohini Podder in Bengaluru; Editing by Shinjini Ganguli)((sohini.podder@thomsonreuters.com;))","news_type":1,"symbols_score_info":{"DKNG":0.9,"SKLZ":0.9,"SRNGU":0.9}},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"CN"},{"id":346368718,"gmtCreate":1617998807134,"gmtModify":1631891944479,"author":{"id":"3569881740421551","authorId":"3569881740421551","name":"Tayhs","avatar":"https://static.tigerbbs.com/18c6192c150a987ab2c12c655cfdfabc","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3569881740421551","authorIdStr":"3569881740421551"},"htmlText":"[开心]&nbsp;","listText":"[开心]&nbsp;","text":"[开心]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/346368718","repostId":2126330720,"repostType":2,"repost":{"id":"2126330720","kind":"highlight","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1617985100,"share":"https://ttm.financial/m/news/2126330720?lang=&edition=full","pubTime":"2021-04-10 00:18","market":"us","language":"en","title":"UPDATE 1-Biotech firm Ginkgo in talks with Harry Sloan-led SPAC for over $20 bln deal","url":"https://stock-news.laohu8.com/highlight/detail?id=2126330720","media":"Reuters","summary":"(Adds confirmation from source)   By Krystal Hu   April 9 (Reuters) - Biotech startup Ginkgo Biowork","content":"<html><body><p>(Adds confirmation from source)</p><p>   By Krystal Hu</p><p>   April 9 (Reuters) - Biotech startup Ginkgo Bioworks is in talks to go public through a merger with a blank-check firm backed by former Hollywood executives Harry Sloan and Jeff Sagansky, in a deal valued at about $20 billion, a person familiar with the matter said.</p><p>   The company is in exclusive talks with Soaring Eagle Acquisition Corp    for a potential business combination and a deal could be announced as soon as this month, the source said on Friday. </p><p>   Soaring Eagle declined to comment on the matter. </p><p>   Boston-based Ginkgo is backed by Bill Gates' private investment firm, Cascade Investment, and hedge fund Viking Global. It received a $1.1 billion loan from the U.S. government in November for COVID-19 testing and production of raw materials for therapies that may help address future pandemics.</p><p>   Soaring Eagle, a special purpose acquisition company (SPAC), raised $1.7 billion through an initial public offering in February. </p><p>   Sloan, a former chief executive officer of Metro Goldwyn Mayer, and Sagansky's former SPACs took gaming firms DraftKings Inc    and <a href=\"https://laohu8.com/S/SKLZ\">Skillz Inc</a>    public. </p><p>   SPACs are shell companies that raise funds through an initial public offering to take a private company public through a merger at a later date.</p><p> (Reporting by Sohini Podder in Bengaluru; Editing by Shinjini Ganguli)</p><p>((sohini.podder@thomsonreuters.com;))</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>UPDATE 1-Biotech firm Ginkgo in talks with Harry Sloan-led SPAC for over $20 bln deal</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nUPDATE 1-Biotech firm Ginkgo in talks with Harry Sloan-led SPAC for over $20 bln deal\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-04-10 00:18</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p>(Adds confirmation from source)</p><p>   By Krystal Hu</p><p>   April 9 (Reuters) - Biotech startup Ginkgo Bioworks is in talks to go public through a merger with a blank-check firm backed by former Hollywood executives Harry Sloan and Jeff Sagansky, in a deal valued at about $20 billion, a person familiar with the matter said.</p><p>   The company is in exclusive talks with Soaring Eagle Acquisition Corp    for a potential business combination and a deal could be announced as soon as this month, the source said on Friday. </p><p>   Soaring Eagle declined to comment on the matter. </p><p>   Boston-based Ginkgo is backed by Bill Gates' private investment firm, Cascade Investment, and hedge fund Viking Global. It received a $1.1 billion loan from the U.S. government in November for COVID-19 testing and production of raw materials for therapies that may help address future pandemics.</p><p>   Soaring Eagle, a special purpose acquisition company (SPAC), raised $1.7 billion through an initial public offering in February. </p><p>   Sloan, a former chief executive officer of Metro Goldwyn Mayer, and Sagansky's former SPACs took gaming firms DraftKings Inc    and <a href=\"https://laohu8.com/S/SKLZ\">Skillz Inc</a>    public. </p><p>   SPACs are shell companies that raise funds through an initial public offering to take a private company public through a merger at a later date.</p><p> (Reporting by Sohini Podder in Bengaluru; Editing by Shinjini Ganguli)</p><p>((sohini.podder@thomsonreuters.com;))</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"DKNG":"DraftKings Inc.","SRNGU":"Soaring Eagle Acquisition Corp.","SKLZ":"Skillz Inc"},"source_url":"http://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2126330720","content_text":"(Adds confirmation from source)   By Krystal Hu   April 9 (Reuters) - Biotech startup Ginkgo Bioworks is in talks to go public through a merger with a blank-check firm backed by former Hollywood executives Harry Sloan and Jeff Sagansky, in a deal valued at about $20 billion, a person familiar with the matter said.   The company is in exclusive talks with Soaring Eagle Acquisition Corp    for a potential business combination and a deal could be announced as soon as this month, the source said on Friday.    Soaring Eagle declined to comment on the matter.    Boston-based Ginkgo is backed by Bill Gates' private investment firm, Cascade Investment, and hedge fund Viking Global. It received a $1.1 billion loan from the U.S. government in November for COVID-19 testing and production of raw materials for therapies that may help address future pandemics.   Soaring Eagle, a special purpose acquisition company (SPAC), raised $1.7 billion through an initial public offering in February.    Sloan, a former chief executive officer of Metro Goldwyn Mayer, and Sagansky's former SPACs took gaming firms DraftKings Inc    and Skillz Inc    public.    SPACs are shell companies that raise funds through an initial public offering to take a private company public through a merger at a later date. (Reporting by Sohini Podder in Bengaluru; Editing by Shinjini Ganguli)((sohini.podder@thomsonreuters.com;))","news_type":1,"symbols_score_info":{"DKNG":0.9,"SKLZ":0.9,"SRNGU":0.9}},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"CN"},{"id":346302438,"gmtCreate":1617985867624,"gmtModify":1634295353335,"author":{"id":"3570864790458781","authorId":"3570864790458781","name":"Yeong","avatar":"https://static.tigerbbs.com/93092185d223c6e53fcfd64303836612","vip":1,"crmLevel":3,"crmLevelSwitch":0,"idStr":"3570864790458781","authorIdStr":"3570864790458781"},"htmlText":"It going to be hot","listText":"It going to be hot","text":"It going to be hot","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/346302438","repostId":2126330720,"repostType":2,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"}],"isCommentEnd":false,"newsSizeData":{"likeSize":4,"commentSize":3,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.3","shortVersion":"4.34.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2126330720"}